OR WAIT 15 SECS
Ellman International, a developer of radiofrequency technology for precision surgical and aesthetic procedures, has announced its acquisition of Sandstone Medical Technologies, developer of aesthetic laser and intense pulsed light technologies.
Oceanside, N.Y. - Ellman International, a developer of radiofrequency (RF) technology for precision surgical and aesthetic procedures, has announced its acquisition of Sandstone Medical Technologies, developer of aesthetic laser and intense pulsed light (IPL) technologies.
The acquisition will merge Sandstone’s line of laser systems with Ellman’s aesthetic and surgical RF product portfolio, the company states. Financial terms of the deal were not disclosed.
“Sandstone is an ideal fit to further the growth of our franchise. We have complementary businesses that focus on delivering physicians high-quality, value-based products, and we believe we are well positioned to capitalize on this $1.8 billion and growing global market opportunity,” says Frank D’Amelio, CEO of Ellman International.
“We have experienced double-digit growth over the past several years due to the success of both Pellevé and our RF surgical generators. We expect this acquisition to accelerate our growth and penetration of the aesthetic market,” he adds.
The Sandstone line consists of four products:
• Cortex, a laser combining CO2 and erbium:YAG for deep skin resurfacing and superficial rejuvenation;
• Tri-Lase Q-switched Nd:YAG and er:YAG laser for treatment of tattoos and pigmented lesions as well as superficial skin rejuvenation;
• Apex IPL and er:YAG laser for hair reduction, acne, vascular and pigmented lesions and skin rejuvenation;
• Cheveux diode laser for permanent hair reduction.
Sandstone’s founder and president, Mark Rohrer, has joined the Ellman management team as executive vice president, aesthetics. “The combination of Sandstone’s products with Ellman’s strong domestic sales and marketing team and extensive international distribution network will be great for the customers that Ellman is targeting,” he says.